| | Business Summary | | Pharmacia
Corporation
is
a
pharmaceutical
company
that
operates
in
three
segments:
Prescription
Pharmaceuticals,
Agricultural
Productivity,
and
Seeds
and
Genomics.
The
Prescription
Pharmaceuticals
segment
involves
the
business
and
activities
engaged
in,
supporting
or
related
to
the
research,
development,
registration,
manufacture
and
sale
of
prescription
pharmaceutical
products.
The
Agricultural
Productivity
segment
consists
of
crop
protection
products,
animal
agriculture
and
the
environmental
technologies
business
lines.
The
Seeds
and
Genomics
segment
is
comprised
of
the
global
seeds,
and
related
trait
businesses
and
genetic
technology
platforms. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | Pharmacia
Corp.
is
engaged
in
the
research,
development,
manufacture
and
sale
of
pharmaceuticals
and
other
related
health
care
products
and
agricultural
products.
For
the
six
months
ended
6/30/01,
revenues
rose
6%
to
$9.94
billion.
Net
income
from
continuing
operations
before
acct.
change
and
extraordinary
items
applicable
to
Common
totalled
$1
billion,
up
from
$501
million.
Revenues
reflect
volume
increases.
Earnings
also
reflect
decreased
merger
and
restructuring
charges. | | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Fred Hassan, 55
Chairman,
CEO | $3.5M | -- | Christoher Coughlin, 48
CFO,
Exec. VP | -- | -- | Goran Ando, M.D., 51
Exec.
VP and Pres, R&D | 1.5M | $5.4M | Carrie Cox, 43
Exec.
VP and Pres, Global Prescription Bus. | -- | -- | Philip Needleman,Ph.D., 62
Sr.
Exec. VP, CSO and Chairman, R&D | 2.6M | 6.7M | | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/p/pha.gif)